Why the study?
Clinical guidelines have recently recommended genetic testing in patients with cardiomyopathies, driven by technological advances and cost reductions in next-generation sequencing.
Key points are not available for this paper at this time.
Design
Review
Genetic testing may refine cardiomyopathy diagnosis; leaves open prospective outcome data before routine adoption.
Precision Medicine is an innovative clinical approach that uses a wide range of data to assess patients, including genetic and molecular information. Thanks to technological advances and cost reductions, new technologies have been incorporated into clinical practice, such as next-generation sequencing methods. Recently, clinical guidelines have recommended the use of genetic tests in patients with cardiomyopathies, which can have a major impact on etiological diagnosis, prognosis, treatment, and family screening. Furthermore, biomarkers obtained by means of imaging tests, wearables, [...]
No takes yet. Share an insight, caveat, or question.
Giugni et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: